How This Actually Works, Step by Step

Here is the honest sequence. You gather your existing records: CT or MRI imaging (DICOM files, not just PDF reports), biopsy pathology slides if a sample was already taken, blood work, and any prior treatment notes. A reputable coordinator translates the key documents into Chinese and routes the full packet to the international department of a shortlisted hospital.

The urology or oncology department then decides whether your case warrants a multidisciplinary review. Not every kidney mass does. A small, clearly benign cyst does not need a tumor board. A complex renal cell carcinoma with vascular involvement absolutely does.

If accepted, your case gets slotted into the next scheduled board meeting. You receive a written summary — in English — covering the consensus recommendation, alternative approaches discussed, and any additional imaging the team wants before committing to a plan.

From there, you choose: proceed with treatment in China, or take that written opinion back to your home physician. Both are legitimate outcomes. Our role at China Medical Services is coordination and translation, not diagnosis. We do not practice medicine and we do not promise outcomes.

Who Actually Sits on a Kidney Tumor Board in Shanghai

The composition varies by hospital, but the core is remarkably consistent across Shanghai’s top-tier facilities. A typical renal tumor board includes:

• Urologic oncologists — surgeons who perform partial or radical nephrectomy, and who decide whether surgery is even the right first move
• Medical oncologists — the physicians managing immunotherapy and targeted therapy for advanced or metastatic disease
• Radiologists — subspecialists who read the contrast-enhanced CT and MRI and characterize the mass
• Pathologists — who confirm histology and grade, especially critical when distinguishing clear cell from papillary or chromophobe subtypes
• Interventional radiologists — relevant when ablation is on the table for smaller tumors
• Radiation oncologists — less commonly involved in primary kidney cancer, but present for metastatic sites

A coordinating nurse or case manager usually chairs the logistics. In some hospitals, a dedicated MDT coordinator ensures imaging is loaded and prior notes are summarized before the meeting starts.

What surprises many international patients: the board does not always recommend surgery. For a small renal mass under 4 cm in an elderly patient with significant comorbidities, active surveillance is a genuine, evidence-based option. A good board says so.

A Realistic Timeline

Patients consistently underestimate the administrative runway. Here is what the sequence typically looks like, with ranges rather than best-case numbers.

Total from first contact to a written board opinion: often 2–5 weeks. Total to actually being examined in Shanghai: 4–8 weeks for most patients, longer if visa processing stalls.

What Can Go Wrong — and What Happens Then

Plenty can go sideways. Here is the unvarnished version.

Your imaging is inadequate. This is the most common failure. Kidney masses need multiphase contrast CT or MRI. If your home scan was a single-phase study, the board may ask for repeat imaging — which means either sending you to a local facility or waiting until you arrive in Shanghai. That adds weeks.

The board declines your case. Sometimes a case genuinely does not need multidisciplinary review. That is not a rejection of you; it is triage. The alternative is a standard specialist consultation, which is faster and cheaper.

The recommendation conflicts with your home doctor’s. This happens more than people expect. When it does, you have two written opinions and a decision to make. We can help you obtain a second Chinese opinion, but we cannot tell you whose judgment is correct. That is your call, ideally with a physician you trust.

You cannot get a visa in time. S2 processing timelines shift with consulate workload. Never book flights before the visa is in hand. For stays beyond 180 days, the category is S1 — but treatment plans rarely require that.

The tumor is more advanced than imaging suggested. Staging can change after in-person evaluation. A plan built on a written opinion may need revision. This is normal, and it is why the board’s recommendation is a direction, not a contract.

How to Judge Whether a Board Review Is Worth It

Not every kidney tumor needs a multidisciplinary review. Here is a practical filter.

If your mass is small, biopsy-confirmed, and your home urologist has a clear plan, a Chinese board adds limited value. If any of the following apply, the review is worth considering: the tumor is larger than 7 cm, there is suspected venous thrombus, imaging is ambiguous between benign and malignant, you have a solitary kidney, you have metastatic disease where systemic therapy sequencing matters, or your home team has offered conflicting recommendations.

Cost is also a factor. A written second opinion from a top-tier Chinese hospital typically runs $300–500. A multidisciplinary team video consultation runs $1,500–2,000. Compare that against the cost of traveling to Shanghai for an in-person evaluation that might have been avoidable.

One useful benchmark: any consultation fee you pay is credited in full toward on-the-ground coordination if you proceed with treatment in China within 90 days. That credit applies to the coordination fee only, never to hospital treatment charges.

Practical Considerations: Records, Visa, Payment, and Language

Records. Send DICOM files, not screenshots. Ask your imaging center for a disc or a secure download link. Pathology slides matter if a biopsy was done — a written report alone is sometimes insufficient for the Chinese pathologist to confirm grade.

Visa. Medical travel to China uses the S2 category, with the purpose of visit noted as medical treatment. Accompanying family members apply under the same category. The M visa is a commercial and trade visa and has nothing to do with medical care — anyone telling you otherwise is misinformed. Requirements shift, so confirm current rules with the relevant Chinese embassy or consulate before applying.

Payment. Public hospitals require prepayment; insurance reimbursement happens afterward. Private international hospitals often bill insurers directly. Budget for the possibility that your home insurer will not cover treatment abroad without prior authorization.

Language. This is not a minor detail. A top Shanghai hospital may see 10,000+ outpatient visits in a single day. Navigating registration, payment, imaging, and pharmacy without Mandarin is genuinely difficult. Bilingual medical companions exist for exactly this reason — from $300 per day for a half or full day of queueing, translation, and accompaniment. We do not guarantee booking a specific named specialist; we coordinate through official international departments and refund the coordination fee if the appointment cannot be secured.

For a broader view of how Chinese hospitals are tiered and ranked, see our guide to top-ranked hospitals by city.

Frequently Asked Questions